Thalassemic Hemoglobinopathies

Total Page:16

File Type:pdf, Size:1020Kb

Thalassemic Hemoglobinopathies REVIEW ARTICLE Thalassemic Hemoglobinopathies MARTIN H. STEINBERG, MD, From the Veterans Administration Medical Center and Department and JUNIUS G. ADAMS, PhD of Medicine, University of Mississippi School of Medicine, Jackson, Mississippi Hemoglobinopathies are due to changes in the normal produce a hemoglobinopathy with features of thalasse- amino acid sequence of globin. Thalassemias result mia. In this review the authors discuss such disorders from imbalance in the normal coordinated synthesis of and include the Hb Lepore and Constant Spring vari- the globin subunits that make up the hemoglobin tet- ants, hyper-unstable globins, mutations which create ramex It is now apparent that a single globin gene can alternative sites for mRNA splicing, and amino acid have coding region mutations which simultaneously substitutions likely to be associated with an additional produce a structural defect (hemoglobinopathy) and a thalassemia lesion within the same gene. (Am J Pathol biosynthetic defect (thalassemia). It is likely that two 1983, 113:396-409) distinct mutations within the same gene can occur and THE GENES that specify the structure and direct the junction for splicing to cleanly and faithfully take synthesis of globin have been assigned to specific place. I chromosomal regions,"2 mapped by restriction en- Hemoglobinopathies are disorders of the primary donuclease analysis,3-6 and completely sequenced.'-" structure of globin and are most often due to the The a and a-like embryonic C genes are located on the substitution of a single amino acid.18 The biosyn- short arm of Chromosome 161 as shown in Figure la. thesis of structural variants is generally normal except The a-globin genes are duplicated, as are most globin for hemoglobinopathies caused by 6(3-fusion genes genes.3 The short arm of Chromosome 11 contains (Lepore hemoglobins)18"9 or by mutations in the the P-like globin gene cluster2 that includes the em- a-globin chain termination codon (Constant Spring bryonic E-gene, the paired y-globin genes and adult 6- hemoglobins).'18"9 In distinction, the thalassemias and P-globin genes (Figure lb). Several varieties of result from disruption of the usual coordinated syn- thalassemia involve deletion of globin genes or of thesis of the globin chains that comprise tetrameric portions of these genes. The extent of deletion in hemoglobin.'9 With the above exceptions, the pri- these varieties of thalassemia is illustrated beneath mary structure of globin in thalassemia was con- each gene cluster. sidered to be normal,20 the clinical manifestations of A more detailed picture of the structure of a globin the disease a result of suboptimal synthesis of the in- gene is shown in Figure 2, along with the process of volved globin chain. gene transcription, mRNA processing, and mRNA The thalassemia phenotype includes combinations translation. Of special note for this review is the and varying degrees of hypochromia and microcy- process of RNA splicing wherein the intervening tosis, anemia, reticulocytosis, splenomegaly, and sequences (introns) are cleanly excised from precursor erythroid bone marrow hyperplasia. The most prev- mRNA and the coding segments (exons) are ligated to alent and clinically important thalassemias are the a- form a continuous stretch of mRNA that codes for globin. This process is complex, not yet fully under- stood, and may take place by more than one mech- Supported by Research Funds of the Veterans Adminis- tration and the Mississippi Affiliate of the American Heart anism. 14-16 It is generally believed that specific nucleo- Association. tide sequences are required at the 5' exon-intron Address reprint requests to Martin H. Steinberg, MD (donor) junction and at the 3' intron-exon (acceptor) (151), VA Medical Center, Jackson, MS 39216. 396 Vol. 113 * No. 3 THALASSEMIC HEMOGLOBINOPATHIES 397 CHROMOSOME 16 KbpO I1 20 30 5' *i - Et I -ML 3' C2 *c' lfa, a2 a, M-ED- _, ,NErASIAN, MEE= MED MED CHROMOSOME II Kb 0 10 20 30 40 50 60 5' 3'5I _ -o - se alu_ *12 Gy Ay */1 8 R CLEPORE1 Gd-- AY (,§0)0-THAO _ y HPFI AlHPF±~~ (61)0 THA~ (Y,13)0 THAL7 (Y613n0 THAL~~ (6) THAL~ Figure la-The a-like gene complex showing the duplicated a-genes, a2 and a, and the deletions described in a-thalassemia. The open boxes indicate the possible limits of deletion, while the hatched boxes indicate the maximum extent. Broken edges indicate that the maximum ex- tent is not known. The first two types are seen in blacks. Med refers to the presence of this lesion in Mediterranean populations and Asians to Southeast Asian peoples. b-The p-like gene complex showing the embryonic E gene the duplicated fetal y genes, Gy and Ay and the adult d and p genes with the known varieties of deletion p-thalassemia. HPFH refers to the hereditary persistence of fetal hemoglobin, a thalas- semia-like condition. Wa, Pp,, wPP2 and yC, refer to pseudogenes which have base sequences homologous to expressed genes but due to a variety of sequence changes are incapable of producing a recognizable globin. (Modified from Weatherall and Clegg.'3) and P-thalassemias. Both groups encompass a large genes results in intrauterine or neonatal death (hy- and still growing number of molecular defects that drops fetalis). result in suboptimal globin synthesis. Thalassemia In addition to deletion of genetic material,21-28 can result in either no globin synthesis (31 or ao) or molecular lesions associated with thalassemia include diminished globin synthesis (f3 or a+) directed by the nucleotide substitutions in conserved sequences 5' to defective gene(s).19 As mentioned previously, deletion the protein coding portion of -the gene, which may of genes or portions of genes is a mechanism of pro- "down-regulate" gene transcription2930; intervening ducing thalassemia. Gene deletion is the major cause sequence nucleotide substitutions or deletions that of a-thalassemia. Deletion of one of the four a-glo- alter existing sites or create new sites for intron ex- bin genes results in a clinically normal phenotype cision and exon splicing, impairing mRNA process- referred to as the "silent carrier" or heterozygous ing31-36; and nonsense mutations which introduce a-thalassemia-2. Deletion of two a-globin genes by stop codons into the coding portion of the gene.37-39 either loss of one gene from each chromosome (ho- There have been a number of recent reviews of the mozygous a-thalassemia-2) or both genes from a molecular biology of the thalassemias. 13.4044 single chromosome (heterozygous a-thalassemia-1) For many years structural and thalassemic genes produces a clinically mild phenotype with microcy- were considered to be so closely linked that the pres- tosis and minimal anemia. Deletion of three a-globin ence of one of these mutations on a particular genes results in HbH disease, characterized by a clini- chromosome precluded the presence of the other on cally significant hemolytic anemia. HbH, a tetramer the same chromosome. This concept began to erode of four P-chains, is present in the red cells of individ- with the findings of hemoglobin variants with two uals with this disorder. Deletion of all four a-globin separate amino acid substitutions such as HbC Har- 398 STEINBERG AND ADAMS AJP - December 1983 DNA structure of globin. These alterations may be the a. 5' - - 1 primary cause of thalassemia or be incidental to an t Transcription associated thalassemia lesion. We include in our Nm RNA discussion the Lepore and Constant Spring-like de- b. fects, hyper-unstable globins, coding region defects Processing creating alternative sites for mRNA splicing with associated amino acid substitutions, silent coding C. CAP AAAA... region mutations creating alternative splice sites, and amino acid substitutions which are likely to be as- mRNA sociated with an additional thalassemia mutation on d. CAP F AAAA... the same chromosome. I Translation T Globin The Lepore and Constant Spring-like Hemoglobins -Untranslated These P-like and a-globin variants are considered -Tronslated together because both have extensive differences be- -- Introns tween the structure of the variant and normal globins. Figure 2a-The nucleotide sequences that specify the structure of globin are encoded in discontinuous blocks of DNA called exons. The These differences are caused in the case of Lepore three globin exons are interrupted by two intervening sequences, or hemoglobins by nonhomologous crossing over be- introns; 5' and 3' to the coding sequences are untranslated portions of DNA. The 5' sequences contain specific signals which in part deter- tween 6 and P genes and in the Constant Spring mu- mine the frequency and fidelity of transcriptional events and have tants by termination codon mutation and elongated been termed "promoters." b-In an enzymatically governed pro- cess the entire gene is transcribed into a large nuclear RNA copy, a-globin chains. These variants have been recognized which contains untranslated sequences and introns. c-This as being associated with the thalassemia phenotype large RNA is processed to yield a smaller mRNA, which can be trans- ported to the cytoplasm. During processing the introns are cleanly for a number of years, have been the subject of con- excised and the exons ligated in a process called splicing. A special siderable study, and will not be covered in detail. cap nucleotide is added, and a poly(A) tail attached, which promotes the translational efficiency and stability of mRNA. The above events The Lepore hemoglobins, the first structural vari- are all intranuclear. d-mRNA is translated into globin on the ants to with the thalassemia polyribosomes of the cell cytoplasm. This involves the interplay of be associated phenotype,49 a number of initiation and elongation factors and transfer RNAs that consist of 3 known different 6(3-fusion chains,50-53 convey the specified amino acid to the growing globin polypeptide.
Recommended publications
  • Hemoglobin Variants: Biochemical Properties and Clinical Correlates
    Downloaded from http://perspectivesinmedicine.cshlp.org/ on September 29, 2021 - Published by Cold Spring Harbor Laboratory Press Hemoglobin Variants: Biochemical Properties and Clinical Correlates Christopher S. Thom1,2, Claire F. Dickson3, David A. Gell3, and Mitchell J. Weiss2 1Cell and Molecular Biology Graduate Group, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104 2Hematology Department, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania 19104 3Menzies Research Institute, University of Tasmania, Hobart, Australia Correspondence: [email protected] Diseases affecting hemoglobin synthesis and function are extremely common worldwide. More than 1000 naturally occurring human hemoglobin variants with single amino acid substitutions throughout the molecule have been discovered, mainly through their clinical and/or laboratory manifestations. These variants alter hemoglobin structure and biochem- ical properties with physiological effects ranging from insignificant to severe. Studies of these mutations in patients and in the laboratory have produced a wealth of information on he- moglobin biochemistry and biology with significant implications for hematology practice. More generally, landmark studies of hemoglobin performed over the past 60 years have established important paradigms for the disciplines of structural biology, genetics, biochem- istry, and medicine. Here we review the major classes of hemoglobin variants, emphasizing general concepts and illustrative examples. lobin gene mutations affecting hemoglobin stitutions, antitermination mutations, and al- G(Hb), the major blood oxygen (O2) carrier, tered posttranslational processing (Table 1). are common, affecting an estimated 7% of the Naturally occurring Hb mutations cause a world’s population (Weatherall and Clegg 2001; range of biochemical abnormalities, some of Kohne 2011). These mutations are broadly sub- which produce clinically significant symptoms.
    [Show full text]
  • Hemoglobinopathies: Clinical & Hematologic Features And
    Hemoglobinopathies: Clinical & Hematologic Features and Molecular Basis Abdullah Kutlar, MD Professor of Medicine Director, Sickle Cell Center Georgia Health Sciences University Types of Normal Human Hemoglobins ADULT FETAL Hb A ( 2 2) 96-98% 15-20% Hb A2 ( 2 2) 2.5-3.5% undetectable Hb F ( 2 2) < 1.0% 80-85% Embryonic Hbs: Hb Gower-1 ( 2 2) Hb Gower-2 ( 2 2) Hb Portland-1( 2 2) Hemoglobinopathies . Qualitative – Hb Variants (missense mutations) Hb S, C, E, others . Quantitative – Thalassemias Decrease or absence of production of one or more globin chains Functional Properties of Hemoglobin Variants . Increased O2 affinity . Decreased O2 affinity . Unstable variants . Methemoglobinemia Clinical Outcomes of Substitutions at Particular Sites on the Hb Molecule . On the surface: Sickle Hb . Near the Heme Pocket: Hemolytic anemia (Heinz bodies) Methemoglobinemia (cyanosis) . Interchain contacts: 1 1 contact: unstable Hbs 1 2 contact: High O2 affinity: erythrocytosis Low O2 affinity: anemia Clinically Significant Hb Variants . Altered physical/chemical properties: Hb S (deoxyhemoglobin S polymerization): sickle syndromes Hb C (crystallization): hemolytic anemia; microcytosis . Unstable Hb Variants: Congenital Heinz body hemolytic anemia (N=141) . Variants with altered Oxygen affinity High affinity variants: erythrocytosis (N=93) Low affinity variants: anemia, cyanosis (N=65) . M-Hemoglobins Methemoglobinemia, cyanosis (N=9) . Variants causing a thalassemic phenotype (N=51) -thalassemia Hb Lepore ( ) fusion Aberrant RNA processing (Hb E, Hb Knossos, Hb Malay) Hyperunstable globins (Hb Geneva, Hb Westdale, etc.) -thalassemia Chain termination mutants (Hb Constant Spring) Hyperunstable variants (Hb Quong Sze) Modified and updated from Bunn & Forget: Hemoglobin: Molecular, Genetic, and Clinical Aspects. WB Saunders, 1986.
    [Show full text]
  • Hemoglobin C Trait (AC) Hemoglobin Eletrophoresis and a Mean Corpuscular Volume
    Inheritance Pattern for SHOULD WE, THE PARENTS, TAKE A BLOOD TEST? Sickle Cell Disease - SC Before you have your next baby, we suggest that you and Hemoglobin your partner get special blood test. We all have two sets of genes for hemoglobin. One set is passed on to the baby When one parent has sickle cell trait (AS) and the from each parent. The testing should include, at minimum, a C Trait (AC) other has hemoglobin C trait (AC) hemoglobin eletrophoresis and a mean corpuscular volume. A sickle solubility test (sickledex) is not sufficient! & Your Baby Only if both you and your partner are tested can you know their baby exactly what kind of hemoglobin condition your next child A S may have A C could have. Look carefully at the inheritance pattern for the possibilities of having a baby with the SC form of sickle cell disease. A A A counselor can tell you if any of your future children could have a form of sickle cell disease. AA (normal hemoglobin) For more information or Contact your local SCDAA organization or other health A C agency at: AC (hemoglobin C trait) or A S Or contact the SCDAA National Office at the address and AS (sickle cell trait) or telephone number below. Stay connected with Get Connected the first patient powered registry S C SC (a type of sickle cell disease) Register at www.getconnectedscd.com It does not matter what their other babies have, their Sickle Cell Disease next one has the same four possibilities: AA, AC, AS, or SC.
    [Show full text]
  • Phd Thesis Tjaard Pijning
    University of Groningen Divergent or just different Rozeboom, Henriette IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below. Document Version Publisher's PDF, also known as Version of record Publication date: 2014 Link to publication in University of Groningen/UMCG research database Citation for published version (APA): Rozeboom, H. (2014). Divergent or just different: Structural studies on six different enzymes. [S.n.]. Copyright Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons). The publication may also be distributed here under the terms of Article 25fa of the Dutch Copyright Act, indicated by the “Taverne” license. More information can be found on the University of Groningen website: https://www.rug.nl/library/open-access/self-archiving-pure/taverne- amendment. Take-down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum. Download date: 29-09-2021 Divergent or just different Structural studies on six different enzymes Henriëtte Rozeboom Printed by Ipskamp Drukkers, Enschede The research presented in this thesis was carried out in the Protein Crystallography group at the Groningen Biomolecular Sciences and Biotechnology Institute.
    [Show full text]
  • Genetic Modifiers at the Crossroads of Personalised Medicine for Haemoglobinopathies
    Journal of Clinical Medicine Article Genetic Modifiers at the Crossroads of Personalised Medicine for Haemoglobinopathies Coralea Stephanou, Stella Tamana , Anna Minaidou, Panayiota Papasavva, , , Marina Kleanthous * y and Petros Kountouris * y Molecular Genetics Thalassaemia Department, The Cyprus Institute of Neurology and Genetics, Nicosia 2371, Cyprus; [email protected] (C.S.); [email protected] (S.T.); [email protected] (A.M.); [email protected] (P.P.) * Correspondence: [email protected] (M.K.); [email protected] (P.K.); Tel.:+357-2239-2652 (M.K.); +357-2239-2623 (P.K.) Equal contribution; Joint last authorship. y Received: 20 September 2019; Accepted: 5 November 2019; Published: 9 November 2019 Abstract: Haemoglobinopathies are common monogenic disorders with diverse clinical manifestations, partly attributed to the influence of modifier genes. Recent years have seen enormous growth in the amount of genetic data, instigating the need for ranking methods to identify candidate genes with strong modifying effects. Here, we present the first evidence-based gene ranking metric (IthaScore) for haemoglobinopathy-specific phenotypes by utilising curated data in the IthaGenes database. IthaScore successfully reflects current knowledge for well-established disease modifiers, while it can be dynamically updated with emerging evidence. Protein–protein interaction (PPI) network analysis and functional enrichment analysis were employed to identify new potential disease modifiers and to evaluate the biological profiles of selected phenotypes. The most relevant gene ontology (GO) and pathway gene annotations for (a) haemoglobin (Hb) F levels/Hb F response to hydroxyurea included urea cycle, arginine metabolism and vascular endothelial growth factor receptor (VEGFR) signalling, (b) response to iron chelators included xenobiotic metabolism and glucuronidation, and (c) stroke included cytokine signalling and inflammatory reactions.
    [Show full text]
  • Adult, Embryonic and Fetal Hemoglobin Are Expressed in Human Glioblastoma Cells
    514 INTERNATIONAL JOURNAL OF ONCOLOGY 44: 514-520, 2014 Adult, embryonic and fetal hemoglobin are expressed in human glioblastoma cells MARWAN EMARA1,2, A. ROBERT TURNER1 and JOAN ALLALUNIS-TURNER1 1Department of Oncology, University of Alberta and Alberta Health Services, Cross Cancer Institute, Edmonton, AB T6G 1Z2, Canada; 2Center for Aging and Associated Diseases, Zewail City of Science and Technology, Cairo, Egypt Received September 7, 2013; Accepted October 7, 2013 DOI: 10.3892/ijo.2013.2186 Abstract. Hemoglobin is a hemoprotein, produced mainly in Introduction erythrocytes circulating in the blood. However, non-erythroid hemoglobins have been previously reported in other cell Globins are hemo-containing proteins, have the ability to types including human and rodent neurons of embryonic bind gaseous ligands [oxygen (O2), nitric oxide (NO) and and adult brain, but not astrocytes and oligodendrocytes. carbon monoxide (CO)] reversibly. They have been described Human glioblastoma multiforme (GBM) is the most aggres- in prokaryotes, fungi, plants and animals with an enormous sive tumor among gliomas. However, despite extensive basic diversity of structure and function (1). To date, hemoglobin, and clinical research studies on GBM cells, little is known myoglobin, neuroglobin (Ngb) and cytoglobin (Cygb) repre- about glial defence mechanisms that allow these cells to sent the vertebrate globin family with distinct function and survive and resist various types of treatment. We have tissue distributions (2). During ontogeny, developing erythro- shown previously that the newest members of vertebrate blasts sequentially express embryonic {[Gower 1 (ζ2ε2), globin family, neuroglobin (Ngb) and cytoglobin (Cygb), are Gower 2 (α2ε2), and Portland 1 (ζ2γ2)] to fetal [Hb F(α2γ2)] expressed in human GBM cells.
    [Show full text]
  • Hemoglobin C Trait What Does This Mean for My Baby, Me and My Family?
    My Baby Has Hemoglobin C Trait What does this mean for my baby, me and my family? Your baby's newborn screening test showed tell them their chance to have a baby with a that he or she has hemoglobin C trait (this is hemoglobin disease. also referred to as being a “hemoglobin C carrier”). Babies who have hemoglobin C trait What does having a baby with hemoglobin are no more likely to get sick than any other C trait mean for me, my partner and for baby. They do not need any special medical future pregnancies? treatment. Hemoglobin C trait will not change Since your baby has hemoglobin C trait, this into a disease later on. means that either you or your partner or both of you have hemoglobin C trait. In almost all What causes hemoglobin C trait? cases, ONLY ONE OF YOU will have Hemoglobin C trait happens when the part of hemoglobin C trait. the red blood cell that carries oxygen throughout the body is changed. This part that Most people do not know that they have is changed is called hemoglobin. Hemoglobin hemoglobin C trait. Now that your baby is is important because it picks up oxygen in the known to have hemoglobin C trait, both you lungs and carries it to the other parts of the and your partner have the option of being body. tested. Testing involves a blood test. People usually have one type of hemoglobin. IF ONLY ONE OF YOU HAS HEMOGLOBIN This is called hemoglobin A. Babies with C TRAIT, in every pregnancy there is a: hemoglobin C trait have a second type of • 1 in 2 (50%) chance to have a baby with hemoglobin called hemoglobin C, as well as only the usual hemoglobin A.
    [Show full text]
  • Pathological Conditions Involving Extracellular Hemoglobin
    Pathological Conditions Involving Extracellular Hemoglobin: Molecular Mechanisms, Clinical Significance, and Novel Therapeutic Opportunities for alpha(1)-Microglobulin Gram, Magnus; Allhorn, Maria; Bülow, Leif; Hansson, Stefan; Ley, David; Olsson, Martin L; Schmidtchen, Artur; Åkerström, Bo Published in: Antioxidants & Redox Signaling DOI: 10.1089/ars.2011.4282 2012 Link to publication Citation for published version (APA): Gram, M., Allhorn, M., Bülow, L., Hansson, S., Ley, D., Olsson, M. L., Schmidtchen, A., & Åkerström, B. (2012). Pathological Conditions Involving Extracellular Hemoglobin: Molecular Mechanisms, Clinical Significance, and Novel Therapeutic Opportunities for alpha(1)-Microglobulin. Antioxidants & Redox Signaling, 17(5), 813-846. https://doi.org/10.1089/ars.2011.4282 Total number of authors: 8 General rights Unless other specific re-use rights are stated the following general rights apply: Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal Read more about Creative commons licenses: https://creativecommons.org/licenses/ Take down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.
    [Show full text]
  • Pathogenesis of Hemolytic Anemia in Homozygous Hemoglobin C Disease
    Pathogenesis of Hemolytic Anemia in Homozygous Hemoglobin C Disease Samuel Charache, … , Richard J. Ugoretz, J. Richard Spurrell J Clin Invest. 1967;46(11):1795-1811. https://doi.org/10.1172/JCI105670. Research Article Hemoglobin C is less soluble than hemoglobin A in red cells, in hemolysates, and in dilute phosphate buffer. Its relative insolubility may be explained by electrostatic interactions between positively charged β6-lysyl groups and negatively charged groups on adjacent molecules. Red cells from patients with homozygous hemoglobin C (CC) disease exhibit aberrant physical properties which suggest that the cells are more rigid than normal erythrocytes. They pass through membrane filters less readily than normal red cells do, and their viscosity is higher than that of normal cells. Differences from normal cells are exaggerated if mean corpuscular hemoglobin concentration (MCHC) is increased, by suspension in hypertonic salt solution. Increased rigidity of CC cells, by accelerating their fragmentation, may be responsible for formation of microspherocytes. These small dense cells are exceptionally rigid, and probably are even more susceptible to fragmentation and sequestration. Rigidity of CC cells can be attributed to a “precrystalline” state of intracellular hemoglobin, in which crystallization does not occur, although the MCHC exceeds the solubility of hemoglobin in hemolysates. Find the latest version: https://jci.me/105670/pdf The Journal of Clinical Investigation Vol. 46, No. 11, 1967 Pathogenesis of Hemolytic Anemia in Homozygous Hemoglobin C Disease * SAMUEL CHARACHE, C. LOCKARD CONLEY, DAVID F. WAUGH, RICHARD J. UGORETZ,4 AND J. RICHARD SPURRELL WITH THE TECHNICAL ASSISTANCE OF ESTHER GAYLE (From the Department of Medicine, The Johns Hopkins University and Hospital, Baltimore, Maryland, and the Department of Biology, Massachusetts Institute of Technology, Boston, Massachusetts) Abstract.
    [Show full text]
  • Observations on the Minor Basic Hemoglobin Component in the Blood of Normal Individuals and Patients with Thalassemia
    Observations on the Minor Basic Hemoglobin Component in the Blood of Normal Individuals and Patients with Thalassemia H. G. Kunkel, … , U. Müller-Eberhard, J. Wolf J Clin Invest. 1957;36(11):1615-1625. https://doi.org/10.1172/JCI103561. Research Article Find the latest version: https://jci.me/103561/pdf OBSERVATIONS ON THE MINOR BASIC HEMOGLOBIN COMPONENT IN THE BLOOD OF NORMAL INDIVIDUALS AND PATIENTS WITH THALASSEMIA BY H. G. KUNKEL, R. CEPPELLINI, U. MULLER-EBERHARD, AND J. WOLF (From the Rockefeller Institute for Medical Research, and Institute for the Study of Human Variation, and the Departmet of Pediatrics, Colunma Uniewsity, N. Y.) (Submitted for publication March 6, 1957; accepted April 11, 1957) In a previous report (1) a second hemoglobin was collected from a number of New York hospitals. was described which was found at a concentration The specimens from patients with thalassemia were ob- of tained from Italian and Greek individuals in the hema- approximately 3 per cent in the blood of normal tology clinic at the Babies Hospital, Columbia-Presby- adult individuals. It was found to resemble he- terian Medical Center, New York. Five individuals with moglobin E in electrophoretic properties, but iden- thalassemia in two families were obtained from index tity with this abnormal hemoglobin was not estab- cases at Bellevue Hospital. The great majority of lished. This same component probably had been thalassemia trait cases were parents of children with observed severe Cooley's anemia. In all instances the diagnosis of by previous investigators employing the thalassemia was based on the hematological picture. classical Tiselius procedure in occasional speci- Several individuals who were suspected of having thalas- mens of blood from normal persons (2, 3) and semia were excluded from the study because of un- thalassemia patients (4), but had not been defined certain hematological findings.
    [Show full text]
  • Chapter 03- Diseases of the Blood and Certain Disorders Involving The
    Chapter 3 Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50- D89) Excludes2: autoimmune disease (systemic) NOS (M35.9) certain conditions originating in the perinatal period (P00-P96) complications of pregnancy, childbirth and the puerperium (O00-O9A) congenital malformations, deformations and chromosomal abnormalities (Q00-Q99) endocrine, nutritional and metabolic diseases (E00-E88) human immunodeficiency virus [HIV] disease (B20) injury, poisoning and certain other consequences of external causes (S00-T88) neoplasms (C00-D49) symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94) This chapter contains the following blocks: D50-D53 Nutritional anemias D55-D59 Hemolytic anemias D60-D64 Aplastic and other anemias and other bone marrow failure syndromes D65-D69 Coagulation defects, purpura and other hemorrhagic conditions D70-D77 Other disorders of blood and blood-forming organs D78 Intraoperative and postprocedural complications of the spleen D80-D89 Certain disorders involving the immune mechanism Nutritional anemias (D50-D53) D50 Iron deficiency anemia Includes: asiderotic anemia hypochromic anemia D50.0 Iron deficiency anemia secondary to blood loss (chronic) Posthemorrhagic anemia (chronic) Excludes1: acute posthemorrhagic anemia (D62) congenital anemia from fetal blood loss (P61.3) D50.1 Sideropenic dysphagia Kelly-Paterson syndrome Plummer-Vinson syndrome D50.8 Other iron deficiency anemias Iron deficiency anemia due to inadequate dietary
    [Show full text]
  • Sickle Cell Disease
    Sickle cell disease Description Sickle cell disease is a group of disorders that affects hemoglobin, the molecule in red blood cells that delivers oxygen to cells throughout the body. People with this disease have atypical hemoglobin molecules called hemoglobin S, which can distort red blood cells into a sickle, or crescent, shape. Signs and symptoms of sickle cell disease usually begin in early childhood. Characteristic features of this disorder include a low number of red blood cells (anemia), repeated infections, and periodic episodes of pain. The severity of symptoms varies from person to person. Some people have mild symptoms, while others are frequently hospitalized for more serious complications. The signs and symptoms of sickle cell disease are caused by the sickling of red blood cells. When red blood cells sickle, they break down prematurely, which can lead to anemia. Anemia can cause shortness of breath, fatigue, and delayed growth and development in children. The rapid breakdown of red blood cells may also cause yellowing of the eyes and skin, which are signs of jaundice. Painful episodes can occur when sickled red blood cells, which are stiff and inflexible, get stuck in small blood vessels. These episodes deprive tissues and organs, such as the lungs, kidneys, spleen, and brain, of oxygen-rich blood and can lead to organ damage. A particularly serious complication of sickle cell disease is high blood pressure in the blood vessels that supply the lungs (pulmonary hypertension), which can lead to heart failure. Pulmonary hypertension occurs in about 10 percent of adults with sickle cell disease. Frequency Sickle cell disease affects millions of people worldwide.
    [Show full text]